Start typing to search...
License agreement with F.Hoffmann-La Roche Ltd.
Installation, Qualification & Validation
Process validation, stability studies
Commercial production started
Agreement signed with NOVARTIS for contract manufacturing
Launch cephalosporin products from dedicated facility
Launch cream & ointment products from separate facility
HPL Established state-of-the-art facility for Small Volume Parenterals, Ophthalmic, Lyophilized & Bio-generic products
Metered Dose Inhaler (MDI) facility establishment
Marketing & Distribution agreement with MSD Pharmaceuticals Private Limited (a subsidiary of Merck & Co. Inc., USA)
Anti-cancer products launch from HPL dedicated oncology facility
Distribution agreement signed with ELI LILLY
Sergel became number one pharmaceutical brand in Bangladesh
Started dedicated sterile cephalosporin facility
Launched hormone products from HPL dedicated facility
Launched HPL's first product in USA